A way to provide medical care to a patient who is not eligible for treatment by participating in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. This extended approach allows the patient to receive promising anti-cancer treatments that have not yet been approved, when no other treatment is possible.
Facebook
Twitter
LinkedIn
WhatsApp
Compassionate drugs
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
ASCO 2025
Biological Drugs
CAR T treatments
centralny układ nerwowy
Chemotherapy
Genetic Engineering Treatments
Genomic Testing
HER3-DXd
Immunotherapy
innowacyjne terapie onkologiczne
Keytruda
leczenie LMD
leczenie nowotworów mózgu
leki biologiczne
Medical Cannabis
nadzieja dla pacjentów
nowe leczenie raka
nowotwór piersi
onkologia zaawansowana
przerzuty do opon mózgowo-rdzeniowych
rak płuca
Stage 4 Cancer
Targeted Drugs
terapia ADC
TUXEDO-3
